Literature DB >> 19116599

Peripheral neuropathy in an adolescent treated with linezolid.

W Matthew Linam1, Kristen Wesselkamper, Michael A Gerber.   

Abstract

The increased incidence of methicillin-resistant Staphyloccocus aureus infections may increase linezolid use in children. Peripheral neuropathy is a rare adverse effect of linezolid therapy and is more frequent with prolonged courses. We present an adolescent with peripheral neuropathy after 4 months of linezolid therapy and review the literature related to linezolid-induced neuropathies. Children receiving long-term linezolid therapy should be monitored for neuropathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19116599     DOI: 10.1097/INF.0b013e3181945999

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  2 in total

1.  Use of linezolid in neonatal and pediatric inpatient facilities--results of a retrospective multicenter survey.

Authors:  A Simon; E Müllenborn; M Prelog; W Schenk; J Holzapfel; F Ebinger; A Klabunde-Cherwon; J Faber; A H Groll; K Masjosthusmann; C Dohna-Schwake; K Beutel; E Dirkwinkel; T Lehrnbecher; R A Ammann; A Müller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-03       Impact factor: 3.267

2.  Peripheral neuropathy from use of linezolid and metronidazole in a pediatric patient.

Authors:  Athena McConnell; Krista Baerg
Journal:  IDCases       Date:  2021-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.